Medicare patients’ cost burden for specialty psoriasis, PsA drugs remains highSeptember 15, 2021PsoriasisPsoriatic Arthritis
Ask about itch and joint pain in pediatric psoriasis patients, expert advisesSeptember 2, 2021PsoriasisPediatricsPsoriatic Arthritis
Three JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Psoriatic ArthritisPediatricsAtopic Dermatitis
Biologic benefit in psoriasis might extend to arthritis preventionAugust 30, 2021Psoriatic ArthritisPsoriasis
Psoriatic arthritis health care costs continue to rise over timeAugust 24, 2021Psoriatic ArthritisPsoriasis
Western diet promoted skin, joint inflammation in preclinical studyAugust 16, 2021PsoriasisPsoriatic Arthritis
Physicians question the future of TNF inhibitors for psoriasis, PsAAugust 6, 2021Psoriatic ArthritisPsoriasis
‘Gold cards’ allow Texas docs to skip prior authorizationsJuly 16, 2021Business of MedicinePsoriasisPsoriatic ArthritisAtopic DermatitisMixed Topics
Patients on methotrexate show T-cell response to Pfizer vaccineJuly 13, 2021COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Study spanning 2 decades offers insights into pediatric psoriasis trendsJuly 8, 2021PediatricsPsoriasisPsoriatic Arthritis
Malignancy risk: Secukinumab shows long-term safety for psoriasis, PsA, ankylosing spondylitisJuly 1, 2021PsoriasisAtopic DermatitisPsoriatic ArthritisMixed Topics
Biologic treatment mitigates PsA risk in psoriasis patients, study findsJune 24, 2021Psoriatic ArthritisPsoriasis
